Yıl: 2022 Cilt: 27 Sayı: 2 Sayfa Aralığı: 104 - 109 Metin Dili: Türkçe İndeks Tarihi: 25-08-2022

Enfektif Endokarditin Klinik Özellikleri: Tek Merkez Deneyimi

Öz:
Amaç: Enfektif endokarditin (EE) morbidite ve mortalitesi, tanısal ve terapötik ilerlemelere rağmen halen yüksektir. Ek olarak, EE'nin altta yatan risk profili ve prognostik belirleyicileri, bölgesel farklılıklar gösterebilir. EE'nin değişen eğilimlerinin gösterilmesi, daha iyi bir hasta bakımı için faydalı olabilir. Bu amaçla, Türkiye'de EE'nin klinik özelliklerini ve prognostik faktörlerini araştırmayı planladık. Gereç ve Yöntem: 2009-2019 yılları arasında tanı alan EE hastalarının predispozan faktörleri, klinik, ekokardiyografik, mikrobiyolojik ve prognostik bilgileri incelendi. EE ile ilişkili prognostik faktörler, tek değişkenli ve çok değişkenli regresyon analizi ile belirlendi. Bulgular: Toplam 80 hastaya (50 erkek, 30 kadın) EE tanısı kondu. Hastaların yedisinde tekrarlayan EE epizodları vardı. Altta yatan en yaygın durumlar romatizmal kapak hastalığı (20 (%25,00) ve protez kalp kapağı (13 (%16,25)) idi. Altmış yedi (%83,75) hastada sol taraflı vejetasyon, 10 (%12,50) hastada sağ taraflı vejetasyon ve 3 hastada kapak tutulumu olmaksızın kalp cihazı enfeksiyonu vardı. 61 (%76,25) hastada doğal kapak endokarditi saptandı. En yaygın mikrobiyolojik ajan staphylococcus türleri olarak saptanırken bunu streptococcus ve enterococcus türleri izledi. Yirmi bir (%28,25) hasta indeks hastane yatışı sırasında öldü. Komplike klinik seyir, hastane içi mortalitenin en önemli öngördürücüsü olarak saptandı. Sonuç: EE'nin predispozan faktörleri ve altta yatan koşulları hakkındaki bilgiler gelişmektedir. Hastane içi takibinde komplikasyon gelişen hastalar, hastane içi mortalite için en yüksek riske sahiptir.
Anahtar Kelime:

Clinical Characteristics of Infective Endocarditis: Data from A Single Center Experience

Öz:
Objective: The morbidity and mortality of infective endocarditis (IE) is still high despite diagnostic and therapeutic advances. Additionally, underlying risk profile and prognostic determinants of IE may exhibit regional disparities. Demonstration of changing trends of IE might be useful for a better patient care. Therefore, we aimed to explore clinical characteristics and the prognostic factors of IE in Turkey. Material and Method: Predisposing factors, clinical, echocardiographic, microbiologic and prognostic information of the IE patients who were diagnosed between the years 2009-2019 were analysed. Prognostic factors associated with IE were determined by univariate and multivariate regression analysis. Results: A total of 80 patients (50 males, 30 females) were diagnosed with IE. Seven of the patients had recurrent episodes of IE. Rheumatic valve disease (20 (25.00%)) and prosthetic heart valve (13 (16.25%)) were the most common underlying conditions. Sixty-seven (83.75%) patients had leftsided vegetation, 10 (12.50%) patients had right-sided vegetation and 3 patients had cardiac device infection without the involvement of the valves. Native valve endocarditis was detected in 61 (76.25%) patients. Staphylococcus was the most common microbiologic agent followed by streptococcus and enterococcus. Twenty-one (28.25%) patients died during the index hospitalization. The complicated clinical course was the most significant predictor of in-hospital mortality. Conclusion: Knowledge of predisposing factors and underlying conditions of IE are evolving. Patients with complicated in-hospital course have the highest risk for in-hospital mortality.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Cay S, Gürel OM, Korkmaz S. Clinical and epidemiological characteristics of infective endocarditis. Turk Kardiyol Dern Ars 2009; 37:182-6.
  • 2. Şimşek-Yavuz S, Akar AR, Aydoğdu S et al. Consensus report on diagnosis, treatment and prevention of ınfective endocarditis by Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK), Turkish Society of Cardiology (TSC), Turkish Society of Nuclear Medicine (TSNM), Turkish Society of Radiology (TSR), Turkish Dental Association (TDA) and Federation of Turkish Pathology Societies (TURKPATH) Cardiovascular System Study Group. Turk Kardiyol Dern Ars 2020; 48:187-226.
  • 3. Angsutararux T, Angkasekwinai N. Cumulative incidence and mortality of infective endocarditis in Siriraj hospital-Thailand: A 10-year retrospective study. BMC Infect Dis 2019; 19:1-9.
  • 4. Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods M-C, Peetermans WE. Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 2006; 28:196-203.
  • 5. Örün UA, Ceylan Ö, Bilici M et al. Acute rheumatic fever in the Central Anatolia Region of Turkey: a 30-year experience in a single center. Eur J Pediatr 2011; 171:361-8.
  • 6. Hoen B, Alla F, Selton-Suty C. Changing profile of infective endocarditis: results of a 1-year survey in France. ACC Curr J Rev 2002; 11:18-9.
  • 7. Aydin M, Yildiz A, Kaya Z et al. Clinical Characteristics and Outcome of Cardiovascular Implantable Electronic Device Infections in Turkey. Clin Appl Thromb 2015; 22:459-64.
  • 8. Tuǧcu A, Yildirimtürk Ö, Baytaroǧlu C et al. Clinical spectrum, presentation, and risk factors for mortality in infective endocarditis: a review of 68 cases at a tertiary care center in Turkey. Turk Kardiyol Dern Ars 2009; 37:9-18.
  • 9. Math RS, Sharma G, Kothari SS, K et al. Prospective study of infective endocarditis from a developing country. Am Heart J 2011; 162: 6338.
  • 10. Habib G, Lancellotti P, Antunes MJ et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015; 36: 3075- 128.
  • 11. Elbey MA, Akdağ S, Kalkan ME et al. A multicenter study on experience of 13 tertiary hospitals in Turkey in patients with infective endocarditis. Anadolu Kardiyol Derg 2013; 13:523-7.
  • 12. Agca FV, Demircan N, Peker T et al. Infective endocarditis: a tertiary referral centre experience from Turkey. Int J Clin Exp Med 2015; 8:13962-8.
  • 13. Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33: 62-9.
  • 14. Chobanian A V, Bakris GL, Black HR et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289 :2560-72.
  • 15. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J kidney Dis 2002; 39:1-266
  • 16. Sucu M, Davutoğlu V, Ozer O, Aksoy M. Epidemiological, clinical and microbiological profile of infective endocarditis in a tertiary hospital in the South-East Anatolia Region. Turk Kardiyol Dern Ars 2010; 38:107-11.
  • 17. Ozveren O. Infective endocarditis and complications; a single center experience. Turk Kardiyol Dern Arsivi-Archives Turkish Soc Cardiol 2014; 42: 629-34.
  • 18. Heper G, Yorukoglu Y. Clinical, Bacteriologic and Echocardiographic Evaluation of Infective Endocarditis in Ankara, Turkey. Angiology 2002; 53: 191-7.
  • 19. Erbay A, Bodur H, Akıncı E, Çolpan A. Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey. J Hosp Infect 2005; 59: 53-61.
  • 20. Erbay AR, Erbay A, Canga A et al. Risk factors for in-hospital mortality in infective endocarditis: five years’ experience at a tertiary care hospital in Turkey. J Heart Valve Dis 2010; 19: 216-24.
  • 21. Yavuz SŞ. Infective endocarditis in elderly patients. Turk Kardiyol Dern Ars 2017; 45: 56-63.
  • 22. Çay S, Gürel ÖM, Korkmaz Ş. Enfektif endokarditli olgularin klinik ve epidemiyolojik özellikleri. Turk Kardiyol Dern Ars 2009; 37: 182- 6.
  • 23. Osmonov D, Ozcan KS, Erdinler I et al. Cardiac device-related endocarditis: 31-Years’ experience. J Cardiol 2013; 61: 175-80.
  • 24. Kocabaş U, Kaya E, Çakan FÖ. Epidemiological, clinical characteristics and predisposing factors of ınfective endocarditis: A review of 194 cases. J Am Coll Cardiol 2013; 62: 81.
  • 25. Nunes MCP, Gelape CL, Ferrari TCA. Profile of infective endocarditis at a tertiary care center in Brazil during a seven-year period: prognostic factors and in-hospital outcome. Int J Infect Dis 2010; 14: 394-8.
  • 26. Mohananey D, Mohadjer A, Pettersson G et al. Association of vegetation size with embolic risk in patients with infective endocarditis a systematic review and meta-analysis. JAMA Intern Med 2018; 178: 502-10.
  • 27. Fernández Guerrero ML, Goyenechea A, Verdejo C, Roblas RF, de Górgolas M. Enterococcal endocarditis on native and prosthetic valves. Medicine 2007; 86: 363-77.
  • 28. Evans Patterson J, Sweeney AH, Simms M et al. An analysis of 110 serious enterococcal ınfections epidemiology, antibiotic susceptibility, and outcome. Medicine 1995; 74: 191-200.
  • 29. Şimşek-Yavuz S, Şensoy A, Kaşıkçıoğlu H et al. Infective endocarditis in Turkey: aetiology, clinical features, and analysis of risk factors for mortality in 325 cases. Int J Infect Dis 2015; 30: 106-14.
  • 30. Leblebicioglu H, Yilmaz H, Tasova Y et al. Characteristics and analysis of risk factors for mortality in ınfective endocarditis. Eur J Epidemiol 2006; 21: 25-31.
  • 31. Cahill TJ, Baddour LM, Habib G et al. Challenges in ınfective endocarditis. J Am Coll Cardiol 2017; 69: 325-44.
  • 32. Kelchtermans J, Grossar L, Eyskens B et al. Clinical Characteristics of ınfective endocarditis in children. Pediatr Infect Dis J 2019; 38: 453-8.
  • 33. Olmos C, Vilacosta I, Habib G et al. Risk score for cardiac surgery in active left-sided infective endocarditis. Heart 2017; 103: 1435-42.
  • 34. Liang F, Song B, Liu R, Yang L, Tang H, Li Y. Optimal timing for early surgery in infective endocarditis: A meta-analysis. Interact Cardiovasc Thorac Surg 2016; 22: 336-45.
  • 35. Jia L, Wang Z, Fu Q, Bu H, Wei M. Could Early surgery get beneficial in adult patients with active native ınfective endocarditis? A Meta-Analysis. Biomed Res Int 2017; 2017: 1-7.
APA Topal S, Ünlü S, Kızıltunç E, KAYA E, Yalçın Y, Sezenöz B, Candemir M, ABACI A (2022). Enfektif Endokarditin Klinik Özellikleri: Tek Merkez Deneyimi. , 104 - 109.
Chicago Topal Salih,Ünlü Serkan,Kızıltunç Emrullah,KAYA EMİN ERDEM,Yalçın Yakup,Sezenöz Burak,Candemir Mustafa,ABACI ADNAN Enfektif Endokarditin Klinik Özellikleri: Tek Merkez Deneyimi. (2022): 104 - 109.
MLA Topal Salih,Ünlü Serkan,Kızıltunç Emrullah,KAYA EMİN ERDEM,Yalçın Yakup,Sezenöz Burak,Candemir Mustafa,ABACI ADNAN Enfektif Endokarditin Klinik Özellikleri: Tek Merkez Deneyimi. , 2022, ss.104 - 109.
AMA Topal S,Ünlü S,Kızıltunç E,KAYA E,Yalçın Y,Sezenöz B,Candemir M,ABACI A Enfektif Endokarditin Klinik Özellikleri: Tek Merkez Deneyimi. . 2022; 104 - 109.
Vancouver Topal S,Ünlü S,Kızıltunç E,KAYA E,Yalçın Y,Sezenöz B,Candemir M,ABACI A Enfektif Endokarditin Klinik Özellikleri: Tek Merkez Deneyimi. . 2022; 104 - 109.
IEEE Topal S,Ünlü S,Kızıltunç E,KAYA E,Yalçın Y,Sezenöz B,Candemir M,ABACI A "Enfektif Endokarditin Klinik Özellikleri: Tek Merkez Deneyimi." , ss.104 - 109, 2022.
ISNAD Topal, Salih vd. "Enfektif Endokarditin Klinik Özellikleri: Tek Merkez Deneyimi". (2022), 104-109.
APA Topal S, Ünlü S, Kızıltunç E, KAYA E, Yalçın Y, Sezenöz B, Candemir M, ABACI A (2022). Enfektif Endokarditin Klinik Özellikleri: Tek Merkez Deneyimi. Fırat Tıp Dergisi, 27(2), 104 - 109.
Chicago Topal Salih,Ünlü Serkan,Kızıltunç Emrullah,KAYA EMİN ERDEM,Yalçın Yakup,Sezenöz Burak,Candemir Mustafa,ABACI ADNAN Enfektif Endokarditin Klinik Özellikleri: Tek Merkez Deneyimi. Fırat Tıp Dergisi 27, no.2 (2022): 104 - 109.
MLA Topal Salih,Ünlü Serkan,Kızıltunç Emrullah,KAYA EMİN ERDEM,Yalçın Yakup,Sezenöz Burak,Candemir Mustafa,ABACI ADNAN Enfektif Endokarditin Klinik Özellikleri: Tek Merkez Deneyimi. Fırat Tıp Dergisi, vol.27, no.2, 2022, ss.104 - 109.
AMA Topal S,Ünlü S,Kızıltunç E,KAYA E,Yalçın Y,Sezenöz B,Candemir M,ABACI A Enfektif Endokarditin Klinik Özellikleri: Tek Merkez Deneyimi. Fırat Tıp Dergisi. 2022; 27(2): 104 - 109.
Vancouver Topal S,Ünlü S,Kızıltunç E,KAYA E,Yalçın Y,Sezenöz B,Candemir M,ABACI A Enfektif Endokarditin Klinik Özellikleri: Tek Merkez Deneyimi. Fırat Tıp Dergisi. 2022; 27(2): 104 - 109.
IEEE Topal S,Ünlü S,Kızıltunç E,KAYA E,Yalçın Y,Sezenöz B,Candemir M,ABACI A "Enfektif Endokarditin Klinik Özellikleri: Tek Merkez Deneyimi." Fırat Tıp Dergisi, 27, ss.104 - 109, 2022.
ISNAD Topal, Salih vd. "Enfektif Endokarditin Klinik Özellikleri: Tek Merkez Deneyimi". Fırat Tıp Dergisi 27/2 (2022), 104-109.